CD28 and neoplasm: The pMHC‐I and anti‐CD28‐functionalized MNCs@MφCM could efficiently expand and stimulate CD8+ T cells ex vivo and guided reinfused CTLs to tumor tissues through magnetic control, allowing the MRI of the particles.